References
- Weaver SC, Ferro C, Barrera R, et al. Venezuelan equine encephalitis. Annu Rev Entomol. Internet. 2004;49:141–174. [cited 2017 Jul 17]
- Paessler S, Weaver SC. Vaccines for Venezuelan equine encephalitis. Vaccine. 2009;27(Suppl 4):D80–85.
- Strauss JH, Strauss EG. The alphaviruses: gene expression, replication, and evolution. Microbiol Rev. 1994;58:491–562.
- Cain MD, Salimi H, Gong Y, et al. Virus entry and replication in the brain precedes blood-brain barrier disruption during intranasal alphavirus infection. J Neuroimmunol. Internet. 2017;308:118–130. [cited 2018 Feb 10]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5694394/
- Phillips AT, Rico AB, Stauft CB, et al. Entry sites of Venezuelan and western equine encephalitis viruses in the mouse central nervous system following peripheral infection. J Virol. Internet. 2016;90:5785–5796. [cited 2018 Feb 10]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4886771/
- Durrant DM, Ghosh S, Klein RS. The Olfactory bulb: an immunosensory effector organ during neurotropic viral infections. ACS Chem Neurosci. Internet. 2016;7:464–469. [cited 2018 Feb 10]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5775964/
- Howard RS. Poliomyelitis and the postpolio syndrome. BMJ. Internet. 2005;330:1314–1318. [cited 2018 Feb 15]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC558211/
- Li F, Wang Y, Yu L, et al. Viral infection of the central nervous system and neuroinflammation precede blood-brain barrier disruption during Japanese encephalitis virus infection. J Virol. Internet. 2015;89:5602–5614. [cited 2018 Feb 15]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4442524/
- Ronca SE, Dineley KT, Paessler S. Neurological sequelae resulting from encephalitic alphavirus infection. Front Microbiol. 2016;7:959.
- Jahrling PB, Stephenson EH. Protective efficacies of live attenuated and formaldehyde-inactivated Venezuelan equine encephalitis virus vaccines against aerosol challenge in hamsters. J Clin Microbiol. 1984;19:429–431.
- Walton TE, Alvarez O, Buckwalter RM, et al. Experimental infection of horses with an attenuated Venezuelan equine encephalomyelitis vaccine (Strain TC-83). Infect Immun. Internet. 1972;5:750–756. [cited 2018 Feb 10]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC422435/
- Pittman PR, Makuch RS, Mangiafico JA, et al. Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine. Vaccine. 1996;14:337–343.
- Yin F, Sancheti H, Patil I, et al. Energy metabolism and inflammation in brain aging and Alzheimer’s disease. Free Radic Biol Med. 2016;100:108–122.
- Campbell GR, Worrall JT, Mahad DJ. The central role of mitochondria in axonal degeneration in multiple sclerosis. Mult Scler Houndmills Basingstoke Engl. 2014;20:1806–1813.
- Schapira AHV, Olanow CW, Greenamyre JT, et al. Slowing of neurodegeneration in Parkinson’s disease and Huntington’s disease: future therapeutic perspectives. Lancet Lond Engl. 2014;384:545–555.
- Anderson G, Maes M. Neurodegeneration in Parkinson’s disease: interactions of oxidative stress, tryptophan catabolites and depression with mitochondria and sirtuins. Mol Neurobiol. 2014;49:771–783.
- Rahmani Z, Huh K-W, Lasher R, et al. Hepatitis B virus X protein colocalizes to mitochondria with a human voltage-dependent anion channel, HVDAC3, and alters its transmembrane potential. J Virol. Internet. 2000;74:2840–2846. [cited 2016 Jun 13]. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC111774/
- Waris G, K-W H, Siddiqui A. Mitochondrially associated hepatitis B Virus X protein constitutively activates transcription factors STAT-3 and NF-κB via oxidative stress. Mol Cell Biol. Internet. 2001;21:7721–7730. [cited 2016 Jun 13]. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC99943/
- Bouchard MJ, Wang L-H, Schneider RJ. Calcium signaling by HBx protein in hepatitis B virus DNA replication. Science. Internet. 2001;294:2376–2378. cited 2016 Jun 13 Available from: http://science.sciencemag.org.mutex.gmu.edu/content/294/5550/2376
- Kim S-J, Syed GH, Hepatitis SA. C virus induces the mitochondrial translocation of Parkin and subsequent mitophagy. PLoS Pathog. Internet. 2013;9:e1003285. [cited 2018 Feb 10]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3610669/
- Kim S-J, Syed GH, Khan M, et al. C virus triggers mitochondrial fission and attenuates apoptosis to promote viral persistence. Proc Natl Acad Sci. Internet. 2014;111:6413–6418. Available from : http://www.pnas.org/content/111/17/6413
- Narayanan A, Amaya M, Voss K, et al. Reactive oxygen species activate NFκB (p65) and p53 and induce apoptosis in RVFV infected liver cells. Virology. 2014;449:270–286.
- Terasaki K, Won S, Makino S. The C-terminal region of rift valley fever virus NSm protein targets the protein to the mitochondrial outer membrane and exerts antiapoptotic function. J Virol. Internet. 2013;87:676–682. [cited 2016 Jun 13]. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3536385/
- Keck F, Brooks-Faulconer T, Lark T, et al. Altered mitochondrial dynamics as a consequence of Venezuelan equine encephalitis virus infection. Virulence [Internet] 2017;8:1849–1866. [cited 2018 Feb 15]. Available from: https://doi.org/10.1080/21505594.2016.1276690
- Kehn-Hall K, Narayanan A, Lundberg L, et al. Modulation of GSK-3β activity in Venezuelan equine encephalitis virus infection. PLoS One. Internet. 2012;7:e34761. [cited 2016 Dec 1]. Available from: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0034761
- Schoneboom BA, Catlin KM, Marty AM, et al. Inflammation is a component of neurodegeneration in response to Venezuelan equine encephalitis virus infection in mice. J Neuroimmunol. 2000;109:132–146.
- Schoneboom BA, Lee JS, Grieder FB. Early expression of IFN-alpha/beta and iNOS in the brains of Venezuelan equine encephalitis virus-infected mice. J Interferon Cytokine Res Off J Int Soc Interferon Cytokine Res. 2000;20:205–215.
- Peng B-H, Borisevich V, Popov VL, et al. Production of IL-8, IL-17, IFN-gamma and IP-10 in human astrocytes correlates with alphavirus attenuation. Vet Microbiol. 2013;163:223–234.
- Henn A, Lund S, Hedtjärn M, et al. The suitability of BV2 cells as alternative model system for primary microglia cultures or for animal experiments examining brain inflammation. ALTEX. 2009;26:83–94.
- Park J, Choi H, Min J-S, et al. Mitochondrial dynamics modulate the expression of pro-inflammatory mediators in microglial cells. J Neurochem. 2013;127:221–232.
- Lykhmus O, Mishra N, Koval L, et al. Molecular mechanisms regulating LPS-induced inflammation in the brain. Front Mol Neurosci. 2016;9:19.
- Noh H, Jeon J, Seo H. Systemic injection of LPS induces region-specific neuroinflammation and mitochondrial dysfunction in normal mouse brain. Neurochem Int. 2014;69:35–40.
- Park J, Min J-S, Kim B, et al. Mitochondrial ROS govern the LPS-induced pro-inflammatory response in microglia cells by regulating MAPK and NF-κB pathways. Neurosci Lett. 2015;584:191–196.
- Sanchez-Guajardo V, Barnum CJ, Tansey MG, et al. Neuroimmunological processes in Parkinson’s disease and their relation to α-synuclein: microglia as the referee between neuronal processes and peripheral immunity. ASN Neuro. Internet. cited. 2013;5. [cited 2018 Feb 10]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3639751/
- Lannes N, Eppler E, Etemad S, et al. Microglia at center stage: a comprehensive review about the versatile and unique residential macrophages of the central nervous system. Oncotarget. Internet. 2017;8:114393–114413. [cited 2018 Feb 10]. Available from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5768411/
- Ransohoff RM, Khoury JE. Microglia in health and disease. Cold Spring Harb Perspect Biol. Internet.2016;8. [cited 2018 Feb 10]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4691795/
- Andreasson KI, Bachstetter AD, Colonna M, et al. Targeting innate immunity for neurodegenerative disorders of the central nervous system. J Neurochem. Internet. 2016;138:653–693. [cited 2018 Feb 10]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433264/
- Murata T, Goshima F, Daikoku T, et al. Mitochondrial distribution and function in herpes simplex virus-infected cells. J Gen Virol. Internet. 2000;81:401–406. [cited 2016 Jun 13]. Available from: http://jgv.microbiologyresearch.org/content/journal/jgv/10.1099/0022-1317-81-2-401
- Bhatt RS, Kothari ST, Gohil DJ, et al. Novel evidence of microglial immune response in impairment of dengue infection of CNS. Immunobiology. 2015;220:1170–1176.
- Jadhav VS, Krause K-H, Singh SKHIV-1. Tat C modulates NOX2 and NOX4 expressions through miR-17 in a human microglial cell line. J Neurochem. 2014;131:803–815.
- Ambrosius B, Faissner S, Guse K, et al. Teriflunomide and monomethylfumarate target HIV-induced neuroinflammation and neurotoxicity. J Neuroinflammation. Internet. 2017;14. [cited 2018 Feb 9]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346211/
- Jiang R, Ye J, Zhu B, et al. Roles of TLR3 and RIG-I in mediating the inflammatory response in mouse microglia following Japanese encephalitis virus infection. J Immunol Res. 2014;2014:787023.
- Das S, Dutta K, Kumawat KL, et al. Abrogated inflammatory response promotes neurogenesis in a murine model of Japanese encephalitis. PLoS One. Internet. 2011;6. [cited 2018 Feb 9]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3048396/
- Garmashova N, Atasheva S, Kang W, et al. Analysis of Venezuelan equine encephalitis virus capsid protein function in the inhibition of cellular transcription. J Virol. 2007;81:13552–13565.
- Cendrowski J, Mamińska A, Miaczynska M. Endocytic regulation of cytokine receptor signaling. Cytokine Growth Factor Rev. Internet. 2016;32:63–73. [cited 2018 Feb 10]. Available from: http://www.sciencedirect.com/science/article/pii/S1359610116300867
- Streit WJ, Mrak RE, Griffin WST. Microglia and neuroinflammation: a pathological perspective. J Neuroinflammation. Internet. 2004;114 [cited 2018 Jul 8]. doi: 10.1186/1742-2094-1-14
- Pan W, Stone KP, Hsuchou H, et al. Cytokine signaling modulates blood-brain barrier function. Curr Pharm Des. Internet. 2011;17:3729–3740 [cited 2018 Feb 15]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3939622/
- Ronaldson PT, Davis TP. Targeting blood–brain barrier changes during inflammatory pain: an opportunity for optimizing CNS drug delivery. Ther Deliv. Internet. 2011 [cited 2018 Feb 15];2:1015–1041. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3313594/
- Ronaldson PT, Davis TP. Blood-brain barrier integrity and glial support: mechanisms that can be targeted for novel therapeutic approaches in stroke. Curr Pharm Des. Internet. 2012. [cited 2018 Feb 15];18:3624–3644. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3918413/